COCRYSTAL PHARMA, INC.: 10-Q filed 2011-11-21
What COCRYSTAL PHARMA, INC. reported in its quarterly report filed 2011-11-21 (fiscal Q3 2011): 32 published measures, 81 facts as tagged in accession 0001521536-11-000462.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2011-11-21
- Fiscal period
- fiscal Q3 2011
- Accession
- 0001521536-11-000462 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All COCRYSTAL PHARMA, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 10,705,593 | USD | |
| At 2010-12-31 | 7,554,600 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | -177,712 | USD | |
| At 2010-12-31 | -570,665 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 781,725 | USD | |
| At 2010-12-31 | 251,475 | USD | |
| At 2010-09-30 | 174,263 | USD | |
| At 2009-12-31 | 630,462 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | -2,499,703 | USD | 92 |
| 2011-01-01 to 2011-09-30 | -3,611,312 | USD | 273 |
| 2010-07-01 to 2010-09-30 | 256,850 | USD | 92 |
| 2010-01-01 to 2010-09-30 | 395,612 | USD | 273 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-09-30 | 157,568 | USD | 273 |
| 2010-01-01 to 2010-09-30 | 352,438 | USD | 273 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-09-30 | 143,084 | USD | 273 |
| 2010-01-01 to 2010-09-30 | 282,535 | USD | 273 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-09-30 | 428,152 | USD | 273 |
| 2010-01-01 to 2010-09-30 | -352,438 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | -4,372,907 | USD | |
| At 2010-12-31 | -761,595 | USD |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | -0.04 | USD/shares | 92 |
| 2011-01-01 to 2011-09-30 | -0.07 | USD/shares | 273 |
| 2010-07-01 to 2010-09-30 | 0.01 | USD/shares | 92 |
| 2010-01-01 to 2010-09-30 | 0.01 | USD/shares | 273 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-07-01 to 2010-09-30 | 92,000 | USD | 92 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 3,186,605 | USD | |
| At 2010-12-31 | 3,262,133 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-09-30 | 1,950,000 | USD | 273 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | -2,216,292 | USD | 92 |
| 2011-01-01 to 2011-09-30 | -3,105,706 | USD | 273 |
| 2010-07-01 to 2010-09-30 | 288,265 | USD | 92 |
| 2010-01-01 to 2010-09-30 | 718,058 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 6,055,880 | USD | |
| At 2010-12-31 | 4,195,769 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | -283,411 | USD | 92 |
| 2011-01-01 to 2011-09-30 | -505,606 | USD | 273 |
| 2010-07-01 to 2010-09-30 | -123,415 | USD | 92 |
| 2010-01-01 to 2010-09-30 | -323,142 | USD | 273 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 7,796,043 | USD | |
| At 2010-12-31 | 5,034,880 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 2,725,375 | USD | |
| At 2010-12-31 | 970,913 | USD |
Goodwill carrying amount
Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 1,353,574 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 1,826,322 | USD | |
| At 2010-12-31 | 1,397,414 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 4,001,843 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 7,375,208 | USD | 273 |
| 2010-07-01 to 2010-09-30 | 1,826,952 | USD | 92 |
| 2010-01-01 to 2010-09-30 | 4,859,974 | USD | 273 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 3,387,618 | USD | |
| At 2010-12-31 | 2,503,598 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 1,785,551 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 4,269,502 | USD | 273 |
| 2010-07-01 to 2010-09-30 | 2,115,217 | USD | 92 |
| 2010-01-01 to 2010-09-30 | 5,578,032 | USD | 273 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 4,011 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 119,167 | USD | 273 |
| 2010-07-01 to 2010-09-30 | 54,837 | USD | 92 |
| 2010-01-01 to 2010-09-30 | 149,497 | USD | 273 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 67,543,310 | shares | |
| At 2010-12-31 | 37,698,396 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 4,127,652 | USD | |
| At 2010-12-31 | 153,232 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 60,215 | USD | |
| At 2010-12-31 | 43,282 | USD |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 3,792,480 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 6,884,039 | USD | 273 |
| 2010-07-01 to 2010-09-30 | 1,684,248 | USD | 92 |
| 2010-01-01 to 2010-09-30 | 4,461,004 | USD | 273 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 205,352 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 372,002 | USD | 273 |
| 2010-07-01 to 2010-09-30 | 87,867 | USD | 92 |
| 2010-01-01 to 2010-09-30 | 249,473 | USD | 273 |
Interest paid, net
Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-09-30 | 319,872 | USD | 273 |
| 2010-01-01 to 2010-09-30 | 176,181 | USD | 273 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-09-30 | -430,999 | USD | 273 |
| 2010-01-01 to 2010-09-30 | -1,140,380 | USD | 273 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-09-30 | -791,677 | USD | 273 |
| 2010-01-01 to 2010-09-30 | -776,088 | USD | 273 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-09-30 | 1,753,882 | USD | 273 |
| 2010-01-01 to 2010-09-30 | 130,432 | USD | 273 |
Inspect the source
- Entity
- COCRYSTAL PHARMA, INC. / CIK 0001412486
- Captured
- 2026-09-20T08:02:05.848Z
- SEC response SHA-256
4ddb37c0fdc725320702a24acde07528776450e5d3542ebbf59be5aa264a757e
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001412486.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))